0000950142-22-000997.txt : 20220310
0000950142-22-000997.hdr.sgml : 20220310
20220310160419
ACCESSION NUMBER: 0000950142-22-000997
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220308
FILED AS OF DATE: 20220310
DATE AS OF CHANGE: 20220310
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Besthof Robert
CENTRAL INDEX KEY: 0001864650
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38302
FILM NUMBER: 22729035
MAIL ADDRESS:
STREET 1: 1201 NORTH MARKET STREET
STREET 2: SUITE 111
CITY: WILMINGTON
STATE: DE
ZIP: 19801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NRX Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001719406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 822844431
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1201 N. MARKET STREET
STREET 2: SUITE 111
CITY: WILMINGTON
STATE: DE
ZIP: 19801
BUSINESS PHONE: 484-254-6134
MAIL ADDRESS:
STREET 1: 1201 N. MARKET STREET
STREET 2: SUITE 111
CITY: WILMINGTON
STATE: DE
ZIP: 19801
FORMER COMPANY:
FORMER CONFORMED NAME: Big Rock Partners Acquisition Corp.
DATE OF NAME CHANGE: 20171012
4
1
es220233694_4-besthof.xml
OWNERSHIP DOCUMENT
X0306
4
2022-03-08
0
0001719406
NRX Pharmaceuticals, Inc.
NRXP
0001864650
Besthof Robert
C/O NRX PHARMACEUTICALS, INC.
1201 NORTH MARKET STREET, SUITE 111
WILMINGTON
DE
19801
0
1
0
0
Interim CEO
Employee Stock Option
2.61
2022-03-08
4
A
0
100000
2.61
A
2032-03-08
Common Stock
100000
347200
D
Options issued under the NRX Pharmaceuticals, Inc. 2021 Omnibus Incentive Plan. The options vest on March 8, 2023, generally subject to the Reporting Person's continued service for NRX Pharmaceuticals, Inc.
/s/ Robert Besthof
2022-03-10